There is currently a lack of studies specifically assessing C6orf99 function, this research reports that C6orf99 may involve a cuproptosis-related ceRNA network in patients with ER+ BC and its level of expression may be linked to resistance to ET. The gene discussed is LINC02901; the disease is breast cancer.